The analysis of the gut microbiome during liver disease progression led to the identification of biomarkers for related mild cognitive impairment

In this context, maintaining a balanced production of fecal SCFA is more important than individual concentrations. The downregulation of specific microbial metabolic pathways, along with the presence of certain bacterial species, holds promise as early-stage biomarkers and highlights the potential of microbiome-targeted strategies for monitoring and managing liver-related cognitive impairment.

Authors

Institutions

Publication Details

Journal
Frontiers in Microbiology
Published
2025-09-16
DOI
https://doi.org/10.3389/fmicb.2025.1670512
Citations
2
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
2.71
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The analysis of the gut microbiome during liver disease progression led to the identification of biomarkers for related mild cognitive impairment

Víctor Hugo Jarquín‐Díaz, Lola Giner-Pérez, Gaspar Pérez-Martı́nez, Jennifer N. Martínez-Medina et al.
2 citations
Frontiers in Microbiology
Liver Disease Diagnosis and Treatment
2.71
article

The analysis of the gut microbiome during liver disease progression led to the identification of biomarkers for related mild cognitive impairment

Víctor Hugo Jarquín‐Díaz, Lola Giner-Pérez, Gaspar Pérez-Martı́nez, Jennifer N. Martínez-Medina, Juan Gallego, Amparo Urios, Sofia Kirke Forslund, Alessandra Fiorillo, Carmina Montoliú, Franc Casanova‐Ferrer, Alicia Salvador, Salvador Benlloch, Desamparados Escudero‐García, Vicente Felipo, Carla Giménez‐Garzó, Yaiza M. Arenas, Daniela Batallas, Adrià López‐Gramaje
article en
2 citations

Abstract

In this context, maintaining a balanced production of fecal SCFA is more important than individual concentrations. The downregulation of specific microbial metabolic pathways, along with the presence of certain bacterial species, holds promise as early-stage biomarkers and highlights the potential of microbiome-targeted strategies for monitoring and managing liver-related cognitive impairment.

Frontiers in MicrobiologyVol. 16
Universitat de València (ES), Max Delbrück Center (DE), Universidad Cardenal Herrera CEU (ES), Instituto de Salud Carlos III (ES), Humboldt-Universität zu Berlin (DE), Hospital Clínico Universitario de Valencia (ES), Instituto de Agroquímica y Tecnología de Alimentos (ES), Hospital Arnau de Vilanova (ES), INCLIVA Health Research Institute (ES), Centro de Investigacion Principe Felipe (ES)
Openalex Percentile: Top 9%
Liver Disease Diagnosis and Treatment
2.71
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.